ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
177 hedge funds and large institutions have $1.18B invested in Intercept Pharmaceuticals, Inc. in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 54 increasing their positions, 54 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
177
Holders Change
-15
Holders Change %
-7.81%
% of All Funds
3.58%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
32
Increased
54
Reduced
54
Closed
46
Calls
$50.8M
Puts
$55.1M
Net Calls
-$4.24M
Net Calls Change
+$4.44M
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$43.5M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$29M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$28.8M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$21.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$18.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$45.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$26.4M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$20.1M |
| 4 |
JPMorgan Chase & Co
New York
|
-$13.5M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$12.6M |
